Abiopharma

DarioHealth Issues Shareholder Update: Multi-Condition Leadership in Momentum Driven Digital Health Market

enGene Achieves Target Enrollment Milestone for LEGEND Trial Pivotal Cohort

New Form 6-K - Valneva SE Filed: 2025-09-03 AccNo: 0001836564-25-000014 Size: 46 KB

Silo Pharma Notification (SILO)

Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio

New Form 144 - NewAmsterdam Pharma Co N.V. Filed: 2025-09-03 AccNo: 0002004379-25-000005 Size: 4 KB

New Form 8-K - STRATA Skin Sciences, Inc. Filed: 2025-09-03 AccNo: 0001213900-25-083709 Size: 582 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Biomerica, Inc. - United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use

Assertio Holdings, Inc. - Assertio to Participate in the HC Wainwright and Lake Street Conferences in September 2025

Assertio to Participate in the HC Wainwright and Lake Street Conferences in September 2025

New Form 8-K - Phio Pharmaceuticals Corp. Filed: 2025-09-03 AccNo: 0001683168-25-006641 Size: 215 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Nurix Therapeutics, Inc. Filed: 2025-09-03 AccNo: 0001549595-25-000108 Size: 2 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Cellectar Biosciences to Present Data in Poster Presentation at the American Association for Cancer Research Special Conference on Advances in Pancreatic Cancer Research

Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences